Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.

The purpose of this study was to test the hypothesis that a variety of structurally dissimilar peroxisomal proliferators inhibited O2 uptake and caused O2-dependent hepatotoxicity in the perfused rat liver. Aspirin, valproate, ethylhexanol, clofibric acid, ciprofibrate and perfluorooctanoate were selected as a representative group of weak, moderate, and potent peroxisomal proliferators, respectively. All compounds studied inhibited state 3 but not state 4 rates of oxygen uptake in isolated mitochondria (perfluorooctanoate greater than ciprofibrate greater than ethylhexanol greater than clofibric acid greater than aspirin greater than valproate; half maximal inhibition occurred at concentrations ranging from 0.6 to 3.2 mM depending on the compound). Clofibric acid, ethylhexanol and aspirin inhibited oxygen uptake only in upstream, oxygen-rich periportal regions of the perfused liver lobule by 30-40%. Perfusion with the six agents studied caused release of lactate dehydrogenase into the effluent perfusate in a dose-dependent manner and caused damage predominantly in periportal regions of the lobule as reflected by trypan blue uptake. A strong correlation between the concentration of compound needed to inhibit respiration in isolated mitochondria and cause hepatotoxicity in the perfused liver was observed. We propose that peroxisomal proliferators accumulate in the liver due to their lipophilicity where they inhibit actively respiring mitochondria in periportal regions of the liver lobule and cause local toxicity.

[1]  M. Chiga,et al.  MICROBODIES IN EXPERIMENTALLY ALTERED CELLS , 1970, The Journal of cell biology.

[2]  D. Feller,et al.  Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes , 1987, Hepatology.

[3]  B. Lake,et al.  Studies on the hepatic effects of orally administered di-)2-ethylhexyl) phthalate in the rat. , 1975, Toxicology and applied pharmacology.

[4]  T. Smith-Oliver,et al.  The Potential Role of Chemically Induced Hyperplasia in the Carcinogenic Activity of the Hypolipidemic Carcinogens , 1987, Toxicology and industrial health.

[5]  R. Hess,et al.  NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT , 1965, Nature.

[6]  R. Scholz,et al.  Interaction of mixed-function oxidation with biosynthetic processes. 1. Inhibition of gluconeogenesis by aminopyrine in perfused rat liver. , 1973, European journal of biochemistry.

[7]  R. Thurman,et al.  Measuring rates of O2 uptake in periportal and pericentral regions of liver lobule: stop-flow experiments with perfused liver. , 1983, The American journal of physiology.

[8]  R. Cattley,et al.  Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. , 1988, Cancer research.

[9]  B. Lake,et al.  Peroxisome proliferation in primary cultures of rat hepatocytes. , 1983, Toxicology and applied pharmacology.

[10]  A. LeBouton.  Protein Synthesis and Secretion , 1986 .

[11]  Theodor Bücher,et al.  Barbiturate und energieliefernder Stoffwechsel in der hämoglobinfrei durchströmten Leber der Ratte , 1966 .

[12]  P. Eacho,et al.  Conditions influencing the induction of peroxisomal beta-oxidation in cultured rat hepatocytes. , 1986, Toxicology letters.

[13]  Reddy Jk,et al.  Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans , 1983 .

[14]  James H. Torrie,et al.  Principles and procedures of statistics: a biometrical approach (2nd ed) , 1980 .

[15]  J. Warren,et al.  HEPATIC AND RENAL EFFECTS OF PEROXISOME PROLIFERATORS: BIOLOGICAL IMPLICATIONS * , 1982, Annals of the New York Academy of Sciences.

[16]  J. Lemasters,et al.  New Micromethods for Studying Sublobular Structure and Function in the Isolated, Perfused Rat Liver , 1986 .

[17]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[18]  M. Rao,et al.  Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. , 1989, Cancer letters.

[19]  J. Reddy,et al.  Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. , 1989, Cancer research.

[20]  R. Melnick,et al.  Effect of phthlate esters on energy coupling and succinate oxidation in rat liver mitochondria , 1985 .

[21]  S. Belinsky,et al.  Trypan blue uptake as a new method to investigate hepatotoxicity in periportal and pericentral regions of the liver lobule: studies with allyl alcohol in the perfused liver. , 1984, The Journal of pharmacology and experimental therapeutics.

[22]  P. Pedersen,et al.  Antihyperlipidemic drugs-In vitro effect on the function and structure of rat liver mitochondria , 1977 .

[23]  W. Jones,et al.  The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. , 1987, Drug metabolism reviews.

[24]  R. Liebelt,et al.  Effect of partial hepatectomy on tumor incidence in BALB-c mice treated with urethan. , 1970, Cancer research.

[25]  G. Kennedy,et al.  Inhalation toxicity of ammonium perfluorooctanoate. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[26]  D. Anderson,et al.  Metabolism and disposition of clarithromycin in man. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[27]  W. C. Schneider,et al.  INTRACELLULAR DISTRIBUTION OF ENZYMES V. FURTHER STUDIES ON THE DISTRIBUTION OF CYTOCHROME c IN RAT LIVER HOMOGENATES , 1950 .

[28]  K. Jungermann,et al.  Regulation of Hepatic Metabolism , 1986, Springer US.

[29]  J. Ward,et al.  The chronic hepatic or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. , 1988, Toxicology and applied pharmacology.

[30]  R. Thurman,et al.  Hepatotoxicity due to clofibrate is oxygen-dependent in the perfused rat liver. , 1990, Toxicology and applied pharmacology.

[31]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .

[32]  D. Azarnoff,et al.  Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. , 1979, Cancer research.